Glo Glossary

One of the most common early side effects - especially around dose increases. Caused primarily by slowed gastric emptying: food sits in the stomach longer than the body is used to, and the brain is receiving stronger fullness signals than usual. For most people it improves as the body adjusts, particularly after the first few weeks at each dose level.

• Eat smaller amounts at a time
• Slow down while eating - put the fork down between bites
• Stick to lighter, simpler foods
• Avoid rich, greasy, or heavily spiced meals
• Stay upright after eating
• Sip cool water slowly
• Get some fresh air if it hits suddenly

Nausea that is severe, completely prevents eating or drinking, or doesn't improve after the adjustment period at a given dose is worth contacting your prescriber about. Any nausea accompanied by significant abdominal pain - not just discomfort, but real pain - should be addressed promptly.

Less common than nausea but it does happen - particularly when eating too quickly, eating heavy foods, or adjusting to a dose increase. Occasional vomiting is in the side effect profile for these medications and typically reflects the stomach pushing back against being overloaded during a slow-emptying period.

• Eat much smaller amounts than you think you need
• Eat small amounts of carbohydrates throughout the day
• Give yourself more time between bites than feels necessary
• Choose bland, simple foods until things settle
• Sip fluids slowly rather than drinking large amounts at once
• Rest after eating - don't rush into activity

Vomiting that is persistent, severe, or making it impossible to keep any fluids down warrants a call to your prescriber. Vomiting accompanied by significant abdominal pain - particularly pain that doesn't ease up - should be addressed the same day.

Extremely common on GLP-1 medications and consistently underreported. Because the medication slows digestion throughout the GI tract, bowel movements often become less frequent and sometimes harder. Going from daily to once every several days is not unusual. It's one of the most common side effects across the entire medication class.

• Increase water intake - consistently, throughout the day, not all at once
• Add more fiber-rich foods gradually (vegetables, fruit, legumes, whole grains)
• Move your body - even a short walk can help things along
• Don't ignore the urge when it comes
• Warm liquids in the morning can help stimulate movement

Constipation that becomes painful, lasts more than a week without any movement, or is accompanied by significant bloating, cramping, or nausea beyond what's typical should be raised with your prescriber. Don't push through significant discomfort alone.

Can occur - often in the earlier weeks or after a dose increase - and sometimes alternates with constipation as the GI tract adjusts. Usually temporary. Staying hydrated is the most important thing during any bout of diarrhea.

• Sip fluids steadily throughout the day - small amounts frequently
• Eat simple, easy-to-digest foods
• Avoid anything rich, fatty, or high in artificial sweeteners
• Rest
• Broth can help with both hydration and electrolytes

Diarrhea that is severe, persists for more than a couple of days, or is making it hard to stay hydrated is a reason to contact your prescriber. Any diarrhea accompanied by significant pain, fever, or blood should be addressed promptly - same day.

GERD (gastroesophageal reflux disease) is chronic acid reflux - stomach acid flowing back into the esophagus. Because GLP-1s slow gastric emptying, food and acid can sit in the stomach longer, increasing the likelihood of reflux. People who already have GERD may notice it worsening on these medications; some people experience it for the first time.

• Eat smaller amounts at each sitting
• Stay upright for at least 30 minutes after eating
• Avoid eating close to bedtime
• Skip the foods most likely to trigger it - fatty meals, citrus, caffeine, carbonated drinks, chocolate
• Elevate your head slightly when sleeping
• Loosen anything tight around your midsection after eating

Reflux that is new, severe, or worsening significantly on these medications is worth discussing with your prescriber rather than managing alone. Any chest pain that doesn't feel like simple heartburn - especially if it radiates or is accompanied by shortness of breath - should be evaluated the same day.

Fatigue shows up early for some people on GLP-1 medications. It can stem from eating significantly less overall, shifts in blood sugar regulation, electrolyte depletion, or simply the body adapting to a new medication. It often improves as intake stabilizes and the body adjusts.

• Pay close attention to protein - it's the most common nutritional gap when appetite is suppressed
• Drink water consistently throughout the day
• Eat something even when appetite is low - small amounts of nutrient-dense food matter
• Rest when the body asks for it
• Get outside for even brief periods of light and movement

Fatigue that is severe, doesn't improve over time, or is accompanied by dizziness, heart palpitations, or significant weakness is worth a conversation with your prescriber. Extreme fatigue alongside symptoms of dehydration - dark urine, dizziness, very low output - should be addressed promptly.

Clinically called telogen effluvium - and one of the most undertalked side effects associated with GLP-1 use. The medication itself isn't directly causing it. Rapid weight loss and the physiological stress of significantly reduced calorie intake are. When the body is under nutritional stress, it deprioritizes hair follicles in favor of vital organs, pushing more hairs than usual into the shedding phase simultaneously. Shedding typically begins 2–3 months after the triggering period and can continue for several months. For most people, it resolves as the body stabilizes. It's more common than it's talked about, and it catches a lot of people off guard. For most people, once the body stabilizes, the follicles cycle back into the growth phase - meaning regrowth is the expected outcome, not permanent thinning.

• Prioritize protein - it's the most evidence-supported nutritional factor for hair during this period
• Eat consistently, even when appetite is low
• Be gentle with hair - minimize heat, tight styles, and aggressive brushing
• Give it time - the timeline is real and the resolution for most people is too

Hair thinning that is severe, continues well beyond several months, or is accompanied by other symptoms like fatigue, cold sensitivity, or changes in skin and nails is worth raising with your prescriber to rule out other contributing factors like thyroid changes or nutritional deficiencies.

Weight loss from any cause involves losing both fat and lean muscle. GLP-1 medications can accelerate the overall pace of weight loss, which means muscle can be lost faster than it otherwise might. Muscle is metabolically active, supports strength and mobility, and is significantly harder to rebuild than fat is to lose. This is one of the most clinically important things to actively protect against during GLP-1 use.

• Eat enough protein - consistently, at every eating occasion
• Incorporate resistance-based movement - anything that works against a load, even bodyweight
• Don't skip eating entirely even on low-appetite days - muscle needs fuel to be maintained
• Stay as physically active as your body allows

Noticeable, rapid loss of strength - difficulty with things that were easy before, significant changes in physical function - is worth discussing with your prescriber rather than attributing entirely to weight loss.

A widely used term for the facial volume loss that can accompany rapid weight loss on GLP-1 medications. As the body loses fat, it loses it everywhere - including in the cheeks, temples, and around the eyes - which can create a gaunt or hollow appearance. The medication isn't directly causing this. Rapid fat loss is. It tends to be more pronounced with faster loss and can be one of the more emotionally unexpected aspects of the process.

• Eating adequate protein and a balanced diet supports overall tissue health during weight loss
• Staying well hydrated affects skin appearance

This is primarily a cosmetic concern rather than a clinical one. If facial changes are significant and distressing, consider a conversation with a dermatologist or cosmetic practitioner - as well as your prescriber about the pace of loss.

Localized responses at the injection site - redness, minor swelling, bruising, itching, or small bumps. Generally mild and short-lived. Very common, especially early on.

• Rotate injection sites consistently - abdomen, thigh, upper arm - and vary the specific spot within each area
• Let the pen warm to room temperature before injecting
• Don't inject into skin that's irritated, bruised, or has an existing reaction
• Apply gentle pressure after injecting - don't rub

A small red spot or minor bump that fades within a day or two is normal. Persistent lumps, significant swelling, spreading redness, warmth, or hardening at a site that doesn't resolve should be mentioned to your prescriber. Any sign of infection - increasing pain, heat, discharge - should be addressed promptly.

Hypoglycemia is when blood sugar drops below normal levels. GLP-1 medications on their own carry a relatively low risk of causing this - they stimulate insulin in a glucose-dependent way, making them less likely to push blood sugar too low independently. The risk increases meaningfully when combined with other diabetes medications like sulfonylureas or insulin, or when food intake is very low over an extended period.

• Eat regularly - don't go long stretches without any food, especially in the early weeks
• Know your symptoms and take them seriously when they show up
• Keep something with fast-acting sugar accessible if your prescriber has advised this based on your specific medication combination

Symptoms of hypoglycemia - shakiness, sweating, dizziness, sudden intense irritability, confusion, or weakness - should be acted on immediately, not observed. If you're on additional medications that affect blood sugar, discuss your specific risk and a response plan with your prescriber before symptoms ever occur. Severe hypoglycemia is a medical emergency.

GLP-1 medications can shift appetite in ways that go beyond simple hunger reduction. Taste preferences sometimes change - foods that were previously appealing become unappealing, and foods that were once ignored become more tolerable. Appetite can become inconsistent, with very little interest in eating some days and more normal signals on others. These shifts are real and can be disorienting.

• Eat on a planned/regular schedule even when appetite isn't signaling hunger - waiting for hunger to cue eating may mean not eating enough
• Explore what foods still appeal and build from there
• Focus on protein and nutrient density when appetite is low rather than volume
• Small, frequent eating occasions tend to work better than waiting for a full appetite

Appetite suppression so significant that meeting basic nutritional needs becomes genuinely difficult over a sustained period - not just a few days - is worth discussing with your prescriber. Very prolonged or complete loss of interest in food can lead to nutritional deficiencies that compound other side effects.

Anhedonia is a reduced ability to feel pleasure or interest in things that used to bring enjoyment - food, hobbies, socializing, sex, things genuinely looked forward to. In the context of GLP-1 use, some people report this experience, and there is a plausible neurological explanation: GLP-1 receptors are present in the brain's reward pathways - the same pathways the medication acts on to quiet food noise. For some people, that effect may extend beyond food-related reward. It's important to be clear: peer-reviewed clinical evidence specifically linking GLP-1 medications to anhedonia is limited at this stage. This is not an FDA-recognized side effect. What exists is a mechanistic hypothesis and a consistent pattern in patient-reported experience that researchers are beginning to pay attention to. Symptoms that might signal it:

• Emotional flatness or a general "meh" quality to things
• Less interest in things that used to bring enjoyment
• Going through the motions without getting much out of them
• Not feeling sad exactly - just not feeling much at all

• Notice it - putting a name to the feeling matters
• Stay socially connected even when the pull to withdraw is strong
• Keep showing up to things that used to bring enjoyment, even without the feeling - the feeling sometimes follows
• Talk about it - with someone you trust, and with your prescriber

If emotional flatness is persistent, worsening, or starting to affect daily functioning and relationships - don't sit on it. This is exactly the kind of thing your prescriber needs to know about. Dose adjustment, timing changes, or additional support can all make a difference. But only if someone on your medical team knows it's happening.

The feeling of a lump or something stuck in the throat - when nothing is actually there. May be related to changes in esophageal motility or to acid reflux. Can come and go or be persistent. Unsettling but not uncommon in GLP-1 users.

• Eat smaller amounts and chew thoroughly
• Stay upright after eating
• Managing reflux if that's a concurrent symptom - the two are often connected

Any persistent throat sensation should be mentioned to your prescriber - both to track it in the context of your medication and to rule out unrelated causes. If it's accompanied by difficulty actually swallowing, pain, or a feeling that food or liquid is getting stuck, don't wait. That's a same-day call.

Inflammation of the pancreas. GLP-1 medications carry a precautionary label regarding pancreatitis risk - this was investigated by the FDA and major cardiovascular outcome trials, including large-scale studies on semaglutide and liraglutide, did not confirm a causal relationship. The association remains an area of ongoing research and the precaution exists for a reason. What matters practically is recognizing the symptoms - because pancreatitis, regardless of cause, requires immediate attention. Symptoms:

• Intense abdominal pain that doesn't let up
• Pain that radiates toward the back
• Nausea and vomiting accompanying the pain

There is no meaningful "wait and see" with pancreatitis symptoms. Deep, severe abdominal pain that doesn't ease up - especially pain that radiates toward the back and comes with nausea and vomiting - is a contact-your-doctor-now situation. If you can't reach your prescriber promptly, go to urgent care or an emergency room. This is not a symptom to manage at home and monitor.

Rapid weight loss - from any cause - significantly increases gallstone risk. When weight comes off quickly, the liver secretes more cholesterol into bile, which can crystallize into stones. GLP-1 medications accelerate weight loss, which makes this risk real. Gallstones can cause severe pain and, if untreated, serious complications. Symptoms include sharp pain in the upper right abdomen - sometimes radiating to the back or right shoulder - nausea, and vomiting, often triggered after eating fatty foods. If you're losing weight rapidly, this is worth raising with your prescriber proactively. Some clinical evidence supports the use of ursodeoxycholic acid (available under brand names including Reltone) to reduce gallstone risk during rapid weight loss. Ask your prescriber or PCP whether that conversation makes sense for you.

Gallbladder pain is not subtle and doesn't tend to resolve quickly on its own. Sharp pain in the upper right abdomen - particularly after a fatty meal - is a call-your-prescriber situation. If the pain is severe or accompanied by fever, yellowing of the skin or eyes, or chills, go to the emergency room. Don't wait for a next-day appointment.

GLP-1 receptor agonists carry a black box warning - the FDA's most serious label - regarding a risk of thyroid C-cell tumors, including a rare cancer called medullary thyroid carcinoma (MTC). This risk was identified in animal studies. Its direct relevance to humans is still being studied, but the warning exists and is included in every medication guide for this class. People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use GLP-1 receptor agonists.

If there is a personal or family history of thyroid cancer - specifically MTC - that is a conversation with your prescriber before starting any GLP-1 medication. Not after. Symptoms that warrant prompt attention while on these medications include a lump or swelling in the neck, hoarseness that develops without obvious cause, difficulty swallowing, or shortness of breath. Any of these should be raised with your prescriber without delay.

A condition in which the stomach empties abnormally slowly - significantly beyond the intentional slowing GLP-1 medications produce by design. Most commonly associated with long-standing diabetes or certain neurological conditions. In people who already have gastroparesis, GLP-1 medications may worsen it. Symptoms that distinguish it from typical GLP-1 adjustment:

• Feeling extremely full after eating very little
• Persistent bloating
• Nausea or vomiting of undigested food
• Ongoing, significant abdominal discomfort

If you have a known history of gastroparesis, that needs to be part of the conversation with your prescriber before starting a GLP-1 medication. If you develop symptoms that go well beyond what's typical for GLP-1 adjustment - particularly vomiting of undigested food or significant persistent discomfort - contact your prescriber. This is not a wait-through-it situation.

Hypoglycemia is when blood sugar drops below normal levels. While GLP-1 medications alone carry a relatively low risk, the risk increases significantly when combined with other diabetes medications - particularly sulfonylureas or insulin - or when food intake is severely restricted over time. It can come on quickly and, when severe, becomes a medical emergency. Symptoms:

• Shakiness or trembling
• Sweating without cause
• Dizziness or lightheadedness
• Sudden, intense irritability or confusion
• Weakness

Symptoms of hypoglycemia require immediate response - not monitoring. If you're on additional medications that affect blood sugar, have a specific conversation with your prescriber about your risk level and what to do if it happens before it ever does. Severe hypoglycemia - confusion, loss of consciousness, inability to manage it independently - is a 911 situation.

GI side effects - nausea, vomiting, diarrhea - can lead to dehydration, and sustained dehydration puts direct strain on the kidneys. There have been reports of acute kidney injury in GLP-1 users, most often connected to inadequate fluid intake during periods of significant GI symptoms. The kidneys need consistent fluid to function properly, and when intake drops sharply, the impact can build faster than expected.

If GI symptoms are making it genuinely difficult to keep fluids down for more than a day, that's a reason to contact your prescriber - not to wait it out and hope hydration improves. Signs that warrant prompt attention: very dark urine or significantly reduced urine output, dizziness on standing, confusion, or extreme fatigue during a period of illness or GI symptoms. These aren't signals to monitor - they're signals to act on the same day.

Abnormal changes in fat tissue at injection sites - either a visible indentation from fat loss (lipoatrophy) or a firm lump from fat accumulation (lipohypertrophy). Caused by repeatedly injecting into the same exact spot. Straightforward to prevent with consistent rotation.

If you notice a dent, lump, or area of hardened tissue at a site you've been using consistently, mention it to your prescriber. Beyond being cosmetically noticeable, injecting into affected tissue can also alter how the medication is absorbed. Rotation prevents it - if it's already present, let your medical team know.

A serious condition in which muscle tissue breaks down rapidly, releasing a protein called myoglobin into the bloodstream. The kidneys must filter it - and in significant amounts, it can cause acute kidney failure. It is rare. It is serious. In the context of GLP-1 use, the risk isn't the medication itself. It's the convergence of factors that can occur simultaneously: significant calorie restriction, dehydration, electrolyte imbalances, and pushing exercise intensity hard without adequate fuel or recovery. When these combine, muscle tissue can break down in ways that overwhelm the kidneys' ability to process it. The warning sign that matters most: dark, brown, or cola-colored urine following physical exertion. This is not a wait-and-see side effect.

Dark urine after exercise is an emergency room conversation - not a next-morning call, not a "drink more water and see." Go. This also means: if you're training hard, eating very little, and not prioritizing hydration and electrolytes, that combination carries real risk. This isn't about scaring anyone away from exercise - movement is important and worth protecting. It's about making sure the body is supported enough to handle it.